Researchers studied the effect of personalized dosing of anti-thymocyte globulin (ATG). They compared the immune recovery and survival of leukemia patients with that of children previously treated with the standard dose of ATG.
from Medindia Health News https://ift.tt/y10VHxSOC
No comments
Post a Comment
Thanks for comment via will connect you within 24 hours.